Lexeo Therapeutics, Inc. Common Stock (LXEO) NASDAQ
5.79
+0.035(+0.61%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
5.79
+0.035(+0.61%)
Currency In USD
| Market Cap | 209.16M |
| Enterprise Value | 184.07M |
| P/E Ratio | -3.36 |
| PEG Ratio | -0.2 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 2.92 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -3.8 |
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | September 30, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.73 |
| Return On Equity | -0.9 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -96.19M |
| Net Income | -98.33M |
| Diluted EPS | -3.09 |
| Total Cash | 41M |
| Total Cash/Share | 0.67 |
| Total Debt | 8.46M |
| Total Debt/Equity | 0.07 |
| Current Ratio | 7.4 |
| Book Value Per Share | 1.98 |
| 52-Week Change | 115.24 |
| 52-Week High | 10.99 |
| 52-Week Low | 1.45 |
| Moving Average 50 Days | 7.26 |
| Moving Average 200 Days | 6.77 |
| Average Volume | 979,338 |
| Shares Outstanding | 72.99M |
| % Held by Institutions | 125.38 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |